XXII Snapshot
22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
Market Capitalization$2,020
Price to Sales0.00
Earnings per Share$0.0000
PE Ratio-20948652
Most Recent Close$3.2100
52 Week High$1.7336
52 Week Low$4.66
50-Day Moving Average$0.55
200-Day Moving Average$3.0574
All data are from Alpha Vantage as of today. For more infomation on XXII see Stock Dividend, Valuation, Price and Financial Data for Investors